Investors Should Review Class Action Against REGENXBIO Inc. for Alleged Securities Fraud Pomerantz Law Firm has initiated a class action lawsuit against REGENXBIO Inc., concerning potential securities fraud. Investors should act promptly by the April 2026 deadline.

Investors Should Review Class Action Against REGENXBIO Inc. for Alleged Securities Fraud #United_States #New_York #REGENXBIO #RGNX #PomerantzLaw